• Contact Us
  • Glossary
  • Useful Websites
  • Download Library
  • Alert Service
  • About Vernalis
  • R & Centre
  • Business Development
  • Investor Centre
  • News Centre
  •  
  • Home

News Centre

Home / News Centre / Vernalis Group Archive / 2002
PrintEmailBookmark
  • Latest Releases
  • Regulatory Announcements
  • Vernalis Group Archive
  • British Biotech Archive
  • RiboTargets Archive
  • Media Contacts

Vernalis Group Archive

  • 2003
  • 2002
Select a Month:
Select a Year:
Search for:
Run your search


Date Title
20/11/2002 Vernalis Group plc (VER) - Vernalis announces first European launch of frovatriptan
27/09/2002 Vernalis Group plc: interim results for the six months ended 30 June 2002
03/09/2002 Frovatriptan highly effective in preventing menstrual migraine
15/08/2002 Frovatriptan menstrual migraine trial ahead of schedule
30/07/2002 Update on Vernalis 5-HT2C obesity programme
18/06/2002 Vernalis Confirms US Launch of Frova™
27/05/2002 Vernalis Group plc: appointment of Non-Executive Director
14/05/2002 Roche and Vernalis announce new collaboration in depression and anxiety
28/03/2002 Vernalis welcomes appointment of US co-promotion partner for Frova™
19/03/2002 Vernalis records profit in second half 2001 following Frova™ milestone payments
Page 1  2    >>
  • Privacy
  • Legal
  • Site Map